A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?

被引:72
作者
Bektas, Arsun [1 ]
Schurman, Shepherd H. [2 ]
Franceschi, Claudio [3 ,4 ,5 ]
Ferrucci, Luigi [1 ]
机构
[1] NIA, Translat Gerontol Branch, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA
[2] NIEHS, Clin Res Branch, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA
[3] Alma Mater Studiorum Univ Bologna, Bologna, Italy
[4] Lobachevsky State Univ, Lab Syst Biol Hlth Aging, Nizhnii Novgorod, Russia
[5] Lobachevsky State Univ, Dept Appl Math, Nizhnii Novgorod, Russia
基金
美国国家卫生研究院;
关键词
Inflammaging; COVID-19; Inflammation; Cytokine storm syndrome; CELLULAR SENESCENCE; ANTIVIRAL DEFENSE; AGE; DISEASE; SEPSIS; INTERLEUKIN-6; DISABILITY; FRAILTY; OBESITY;
D O I
10.1186/s12979-020-00196-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A central clinical question as the world deals with the COVID-19 pandemic is what the long-term sequelae for the millions of individuals will be who recover from the hyperinflammatory state characterizing COVID-19 and in particular for the hundreds of thousands who are ill enough to need hospitalization and in particular ICU care. Even when the pandemic is finally controlled, will COVID-19 survivors face exaggerated internal inflammatory processes, worsening co-morbidities, and increased susceptibility to age-related diseases? Clues for what may happen in post-COVID-19 patients can be elicited from those who recovered from other conditions that lead to similar hyperinflammatory states such as Severe Acute Respiratory Syndrome (SARS), acute respiratory disease syndrome (ARDS), cytokine storm syndrome, and post-ICU syndrome. The short-and long-term sequalae following recovery from each of these conditions suggests that these syndromes lead to an accelerated state of chronic subclinical systemic inflammation often seen in aging (termed inflammaging) resulting in increased and worsening age-related conditions including frailty even in younger individuals.
引用
收藏
页数:10
相关论文
共 70 条
  • [51] Riphagen Shelley, 2020, Lancet, V395, P1607, DOI 10.1016/S0140-6736(20)31094-1
  • [52] Postmortem Examination of Patients With COVID-19
    Schaller, Tina
    Hirschbuehl, Klaus
    Burkhardt, Katrin
    Braun, Georg
    Trepel, Martin
    Maerkl, Bruno
    Claus, Rainer
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (24): : 2518 - 2520
  • [53] The pro- and anti-inflammatory properties of the cytokine interleukin-6
    Scheller, Juergen
    Chalaris, Athena
    Schmidt-Arras, Dirk
    Rose-John, Stefan
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (05): : 878 - 888
  • [54] Inflammation and frailty in the elderly: A systematic review and meta-analysis
    Soysal, Pinar
    Stubbs, Brendon
    Lucato, Paola
    Luchini, Claudio
    Solmi, Marco
    Peluso, Roberto
    Sergi, Giuseppe
    Isik, Ahmet Turan
    Manzato, Enzo
    Maggi, Stefania
    Maggio, Marcello
    Prina, A. Matthew
    Cosco, Theodore D.
    Wu, Yu-Tzu
    Veronese, Nicola
    [J]. AGEING RESEARCH REVIEWS, 2016, 31 : 1 - 8
  • [55] The trinity of COVID-19: immunity, inflammation and intervention
    Tay, Matthew Zirui
    Poh, Chek Meng
    Renia, Laurent
    MacAry, Paul A.
    Ng, Lisa F. P.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2020, 20 (06) : 363 - 374
  • [56] Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
    Tian, Sufang
    Hu, Weidong
    Niu, Li
    Liu, Huan
    Xu, Haibo
    Xiao, Shu-Yuan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 700 - 704
  • [57] Interleukin-6 as a potential biomarker of COVID-19 progression
    Ulhaq, Zulvikar Syambani
    Soraya, Gita Vita
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (04): : 382 - 383
  • [58] Immunology of COVID-19: Current State of the Science
    Vabret, Nicolas
    Britton, Graham J.
    Gruber, Conor
    Hegde, Samarth
    Kim, Joel
    Kuksin, Maria
    Levantovsky, Rachel
    Malle, Louise
    Moreira, Alvaro
    Park, Matthew D.
    Pia, Luisanna
    Risson, Emma
    Saffern, Miriam
    Salome, Berengere
    Selvan, Myvizhi Esai
    Spindler, Matthew P.
    Tan, Jessica
    van der Heide, Verena
    Gregory, Jill K.
    Alexandropoulos, Konstantina
    Bhardwaj, Nina
    Brown, Brian D.
    Greenbaum, Benjamin
    Gumus, Zeynep H.
    Homann, Dirk
    Horowitz, Amir
    Kamphorst, Alice O.
    de Lafaille, Maria A. Curotto
    Mehandru, Saurabh
    Merad, Miriam
    Samstein, Robert M.
    [J]. IMMUNITY, 2020, 52 (06) : 910 - 941
  • [59] An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
    Verdoni, Lucio
    Mazza, Angelo
    Gervasoni, Annalisa
    Martelli, Laura
    Ruggeri, Maurizio
    Ciuffreda, Matteo
    Bonanomi, Ezio
    D'Antiga, Lorenzo
    [J]. LANCET, 2020, 395 (10239) : 1771 - 1778
  • [60] Williamson E, 2020, OPENSAFELY FACTORS A, DOI [10.1101/2020.05.06.20092999, DOI 10.1101/2020.05.06.20092999]